Unlocking the Potential of miRNA-Targeted Therapies
Interest in oligonucleotide therapeutics is growing, with several drugs already approved and many more in development, offering a promising avenue for targeted therapies. However, oligonucleotide therapies targeting microRNA (miRNA) are yet to be successful.
In this webinar, our expert speaker will explore the therapeutic potential of miRNA- targeting treatments, outlining cutting-edge research that is identifying new miRNA targets.
He’ll also discuss the latest methodologies in miRNA research, including next-generation sequencing and miRNA inhibition.
Attend this webinar to:
- Explore a brief history of oligonucleotide therapeutics, from routine failure to routine success
- Learn why oligonucleotide therapeutics targeting miRNAs have not been successful
- Discover how nuclear RNA interference offers a new approach to identifying therapeutic target miRNAs
Speaker
Dr. David Corey
Rusty Kelley Professor of Biomedical Research
UT Southwestern University
Brought to you by
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
